TrialClinical cancer research : an official journal of the American Association for Cancer Research2021

A Randomized, Phase III Study of Lenvatinib in Chinese Patients with Radioiodine-Refractory Differentiated Thyroid Cancer.

Xiangqian Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.